111 related articles for article (PubMed ID: 35384803)
21. Defining long-term outcomes with living donor liver transplantation in North America.
Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
[TBL] [Abstract][Full Text] [Related]
22. Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
Tohyama T; Sakamoto K; Tamura K; Nakamura T; Watanabe J; Wakisaka H; Takada Y
World J Surg Oncol; 2020 May; 18(1):109. PubMed ID: 32466780
[TBL] [Abstract][Full Text] [Related]
23. Large-for-size liver transplant: a single-center experience.
Akdur A; Kirnap M; Ozcay F; Sezgin A; Ayvazoglu Soy HE; Karakayali Yarbug F; Yildirim S; Moray G; Arslan G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():108-10. PubMed ID: 25894137
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
25. Outcome of critically-ill children after living-donor liver transplant.
Elgendy H; El Moghazy WM; Nafady-Hego H; Uemoto S
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():100-7. PubMed ID: 25894136
[TBL] [Abstract][Full Text] [Related]
26. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
Cai J
Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
[TBL] [Abstract][Full Text] [Related]
27. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
Brahmbhatt M; Prenner S; Bittermann T
Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
[TBL] [Abstract][Full Text] [Related]
28. Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria.
Alim A; Erdogan Y; Dayangac M; Yuzer Y; Tokat Y; Oezcelik A
Cancer Control; 2021; 28():10732748211011960. PubMed ID: 33926242
[TBL] [Abstract][Full Text] [Related]
29. Pediatric liver transplantation.
Cuenca AG; Kim HB; Vakili K
Semin Pediatr Surg; 2017 Aug; 26(4):217-223. PubMed ID: 28964477
[TBL] [Abstract][Full Text] [Related]
30. Offspring Versus Nonoffspring to Parent Living Donor Liver Transplantation: Does Donor Relationship Matter?
Dagan A; Choudhury RA; Yaffe H; Yoeli D; Moore HB; Conzen KD; Adams M; Wachs M; Pomposelli JJ; Pomfret EA; Nydam TL
Transplantation; 2020 May; 104(5):996-1002. PubMed ID: 31568397
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation.
Rajakannu M; Vij M; Shaikh TMA; Rammohan A; Reddy MS; Rela M
Indian J Gastroenterol; 2021 Feb; 40(1):30-34. PubMed ID: 33548018
[TBL] [Abstract][Full Text] [Related]
32. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
33. Expanded Criteria for Hepatocellular Carcinoma in Liver Transplant.
Haberal M; Akdur A; Moray G; Arslan G; Özçay F; Selçuk H; Özdemir H
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):55-58. PubMed ID: 28302000
[TBL] [Abstract][Full Text] [Related]
34. A multi-factor analysis of kidney regraft outcomes.
Gjertson DW
Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
[TBL] [Abstract][Full Text] [Related]
35. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
[TBL] [Abstract][Full Text] [Related]
36. De Novo Intrahepatic Cholangiocarcinoma After Deceased Donor Liver Transplant in an Adult Patient.
Moon HH; Shin DH; Choi YI
Exp Clin Transplant; 2022 Mar; 20(3):316-320. PubMed ID: 35352635
[TBL] [Abstract][Full Text] [Related]
37. Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients.
Mogul DB; Luo X; Garonzik-Wang J; Bowring MG; Massie AB; Schwarz KB; Cameron AM; Bridges JFP; Segev DL
Liver Transpl; 2019 Jan; 25(1):119-127. PubMed ID: 30230191
[TBL] [Abstract][Full Text] [Related]
38. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
39. Two Decades of Deceased Donor Kidney Transplantation at Ahmedabad, India.
Kute VB; Patel HV; Modi PR; Rizvi SJ; Shah PR; Engineer DP; Banerjee S; Butala BP; Gandhi S; Mishra VV
Exp Clin Transplant; 2020 Oct; 18(5):549-556. PubMed ID: 33143600
[TBL] [Abstract][Full Text] [Related]
40. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
